Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants

Chem(2022)10.1016/j.chempr.2022.07.012Source: DataRank Database

Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants is a research paper published in Chem (2022). On theSindex it has a DataRank of 0. It has been cited 64 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access64 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.93)OA: bronzeTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Shanshan Li ORCID,Takako Tabata ORCID,Nanxi Wang ORCID,Li Cao ORCID,G. Renuka Kumar ORCID

Live enrichment

PubMed:35874165 PMC:PMC9288967 OpenAlex:https://openalex.org/W4285806329

National Cancer Institute

Grant: R01CA258300

University of California, San Francisco

Grant: 7030487

National Institutes of Health

Grant: R37AI083139

Gladstone Institutes

FWCI

4.93

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S2451929422003710/pdf

publisherhttp://www.cell.com/article/S2451929422003710/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2451929422003710?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2451929422003710?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.chempr.2022.07.012

Fields of Study

SARS-CoV-2 and COVID-19 ResearchBacteriophages and microbial interactionsMonoclonal and Polyclonal Antibodies Research

Keywords

Covalent bondChemistryNeutralizationPotencySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Covalent bindingCombinatorial chemistryCoronavirus disease 2019 (COVID-19)VirologyBiophysicsStereochemistryBiochemistryVirusBiologyIn vitroMedicineInfectious diseaseNanobodyGenetic Code ExpansionProximity-enabled ReactivityCovid-19Sars-cov-2Covalent Protein DrugLatent Bioreactive Unnatural Amino AcidSulfur Fluoride Exchange (Sufex) Click ChemistrySpike-ace2 Interaction

Sustainable Development Goals

SDG 0: Good health and well-being

Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants

FAIR Checklist

Authors (10)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)